Stock comparison
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Vir Biotechnology
VIR$1.49BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
SANOFICONR.NS 70 VIR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
SANOFICONR.NS7wins
0winsVIR
78B
F20
89A
F37
83B
F31
77B
F3
91A
F2
86A
F38
85A
F38
Side-by-side metrics
| Metric | SANOFICONR.NS | VIR |
|---|---|---|
| Market cap | Winner: $104.11B | $1.49B |
| P/E (TTM) | 44.2x | - Winner |
| EV/EBIT | 31.8x | - Winner |
| ROIC (TTM) | Winner: 59.15% | -48.49% |
| Gross margin | 68.13% | 2.75% Winner |
| Net margin | Winner: 27.35% | -6.76% |
| Revenue CAGR 5y | Winner: 27.01% | -49.98% |
| EPS CAGR 5y | 20.67% | - |
| Debt / Equity | Winner: 0.1x | 0.1x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
SANOFICONR.NS leads on
- ROIC (TTM)59.15%vs -48.49%+182%
- Revenue CAGR 5y27.01%vs -49.98%+154%
- Net margin27.35%vs -6.76%+104%
- Market cap$104.11Bvs $1.49B+99%
VIR leads on
- EV/EBIT-vs 31.8x+109%
- P/E (TTM)-vs 44.2x+107%
- Gross margin2.75%vs 68.13%+75%
More like SANOFICONR.NS
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.